ARTICLE | Clinical News
Advanced Viral preclinical data
December 15, 2003 8:00 AM UTC
In a rat model of MS, 14 days of treatment with AVR118 via subcutaneously implanted infusion pumps inhibited the progression of disease. The therapeutic effects ceased when treatment was discontinued....